The use of esketamine in comorbid treatment resistant depression and obsessive compulsive disorder following extensive pharmacogenomic testing: a case report.

Marcatili MatteoPellicioli CristianMaggioni LauraMotta FedericoRedaelli ChiaraGhelfi LorenzoKrivosova MichaelaMatteo SibillaNava RobertoColmegna FabriziaDakanalis AntoniosCaldiroli AliceCapuzzi EnricoBenatti BeatriceBertola FrancescaVilla NicolettaPiperno AlbertoIppolito SilviaClerici Massimo

Published in: Annals of general psychiatry (2021)

This case underlines the importance of pharmacogenomic tests in profiling TRD patients and confirms the possible use of esketamine in the treatment of comorbid OCD.

Keyphrases

obsessive compulsive disorder
end stage renal disease
deep brain stimulation
chronic kidney disease
ejection fraction
newly diagnosed
depressive symptoms
prognostic factors
clinical decision support
peritoneal dialysis
patient reported outcomes
sleep quality
electronic health record
replacement therapy